Colonic dilation and altered ex vivo gastrointestinal motility in the neuroligin-3 knockout mouse.
Anita J L Leembruggen, Gayathri K Balasuriya, Jinghong Zhang and 5 others
PMID 31002480WHAT IT FOUND
In mice lacking the autism-associated Neuroligin-3 gene, gut lining and nerve counts were unchanged, but isolated colon rested wider and contractions moved faster.
This is animal work, not evidence for human therapy.
Key findings
01Mice lacking Neuroligin-3 showed no detectable difference in gut lining structure.
02The deletion did not change the number of gut wall nerve cells.
03Isolated colon from knockout mice rested wider, contracted faster, and showed a smaller speed response to a nitric oxide blocker.
STILL TO COME
How it was doneWhat they found
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This was an animal study in mice, not a study of children or adults with autism. It measured isolated colon tissue, not whole-body digestion, bowel symptoms, pain, constipation, diarrhoea, or response to treatment. The mice were male, and the genetic background strain can influence how severe gut features are. The gene was absent from development, so other genes or pathways may have compensated; this does not show what happens if the gene changes later in life. The study counted nerve cells and some nerve cell types, but did not measure synapse density, nitric oxide levels, or the exact mechanism causing the wider and faster colon.
Declared interests
The supplied text lists non-U.S. government research support. It does not provide an author conflict-of-interest declaration or say who designed the study.
The easy way to misread this
Do not conclude that this identifies a cause of autism-related gut symptoms or a treatment target. The study was done in mice and only in isolated colon tissue; it did not measure human gut function, constipation, or therapy response.